GCNT2 and polycystic ovary syndrome: Studies have indicated that alterations in GCNT2 expression can lead to changes in SHBG levels, further implicating GCNT2 in the pathophysiology of PCOS and its associated symptoms, such as insulin resistance and infertility (13).